PerkinElmer unveils cell analysis to streamline cell and gene therapy research and manufacturing

Oct. 3, 2022
Cellaca PLX Image Cytometer redefines workflows, addresses multiple Critical Quality Attributes.

PerkinElmer, Inc., launched the Cellaca PLX Image Cytometry System, a benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.

The Cellaca PLX system, designed by the company’s Nexcelom unit, combines image cytometer hardware, software, validated consumables and trackable data reporting all in one system without requiring complex calibration procedures or intense training requirements.

The new offering provides researchers expanded cell sample CQA analysis options beyond flow cytometry and staining methods, which historically have required a variety of different instruments and analytical methods. By combining these capabilities, researchers can now detect multiple markers simultaneously (multiplexing) and perform immunophenotyping and viability assays in seconds with an easy-to-use, modern user interface.

Businesswire release